Dr. Anna Astashchanka, MD

Dr. Astashchanka practices at Sharp Memorial Hospital in San Diego, California, part of Sharp HealthCare.

Dr. Astashchanka's NPI, 1821594359, was assigned on April 3, 2018. Dr. Astashchanka graduated from University of Colorado Anschutz Medical Campus in 2018. Dr. Astashchanka's California license number on file is A164791.

Dr. Astashchanka's primary practice is Sharp Memorial Hospital, at 7901 Frost St, San Diego, CA 92123 in San Diego County. The practice phone is (858) 939-3400.

Dr. Astashchanka's primary practice is Sharp Memorial Hospital in San Diego, California, part of Sharp HealthCare. Dr. Astashchanka is also affiliated with Sharp Chula Vista Medical Center. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Astashchanka to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Astashchanka practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Astashchanka's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Astashchanka is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Astashchanka has a license on file in California.

CMS data shows 21 Medicare services from Dr. Astashchanka across 1 procedure code in 2024, for 26 Medicare patients. Medicare paid $3,552 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. Astashchanka in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Astashchanka's median patient age at 67, with 42% women.

In 2024, Dr. Astashchanka wrote 111 Medicare Part D claims for 22 patients. 42% of them were for generic drugs. CMS names the drug for 36 of them, across 3 drugs with 11 or more claims each, at $21,250 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Astashchanka for performance year 2024, reported as part of a group. Dr. Astashchanka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Astashchanka.

CMS Open Payments shows 1 general payment to Dr. Astashchanka from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $32.

Dr. Astashchanka graduated from University of Colorado Anschutz Medical Campus in 2018.

Dr. Astashchanka is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.